Amsino Medical receives significant equity investment from Novo Tellus for global expansion.

Amsino Medical Group, a global provider of medical consumable devices, has received a significant investment from Novo Tellus, a leading investment firm in the global supply chain. The partnership aims to expand Amsino's global production, R&D, and commitment to quality, with the investment made entirely with equity and closing in June 2024. Novo Tellus previously partnered with Amsino between 2011 and 2017, leading to substantial growth during that time.

June 27, 2024
6 Articles

Further Reading